GTG — Genetic Technologies Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Genetic Technologies, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 1.04 | 1.33 | 2.4 | 1.96 | 1.75 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -5.71 | -6.3 | -5.66 | -9.72 | -9.68 |
| Capital Expenditures | -0.038 | -0.749 | -0.097 | -0.018 | -0.033 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.103 | 0 | -3.36 | -0.294 | 0.148 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0.065 | -0.749 | -3.46 | -0.312 | 0.115 |
| Financing Cash Flow Items | -3.3 | -1.97 | -0.01 | -0.916 | -0.007 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 18.4 | 13.7 | -0.279 | 5.92 | 2.82 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 12.1 | 6.69 | -9.17 | -3.88 | -6.83 |